BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 4242004)

  • 1. Neurologic aspects of typical and atypical Down's syndrome.
    Paulson GW; Son CD; Nance WE
    Dis Nerv Syst; 1969 Sep; 30(9):632-6. PubMed ID: 4242004
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurologic aspects of typical and atypical Down's syndrome.
    Paulson GW; Nance W; Son C
    Neurology; 1968 Mar; 18(3):305-6. PubMed ID: 4231810
    [No Abstract]   [Full Text] [Related]  

  • 3. [Report on a case of Down's syndrome with mosaicism. Trisomy 21-normal, clearly mongoloid phenotype and normal iliac index in a newborn infant].
    De Prà M; Lunetta Q
    Minerva Pediatr; 1974 Jan; 26(2):78-81. PubMed ID: 4276194
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome].
    Kjaergaard S; Hahnemann JM; Skibsted L; Jensen LN; Sperling L; Zingenberg H; Kristiansen A; Brøndum-Nielsen K
    Ugeskr Laeger; 2008 Mar; 170(14):1152-6. PubMed ID: 18405480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Karyotype variation and behavior in Down's syndrome: methodological review.
    Gibson D
    Am J Ment Defic; 1973 Sep; 78(2):128-33. PubMed ID: 4272254
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of 5-HTP in the treatment of Down's syndrome.
    Weise P; Koch R; Shaw KN; Rosenfeld MJ
    Pediatrics; 1974 Aug; 54(2):165-8. PubMed ID: 4277102
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dermatoglyphics in typical and atypical Down's syndrome].
    Dallapiccola B; Ricci N
    Acta Genet Med Gemellol (Roma); 1967 Oct; 16(4):384-94. PubMed ID: 4232217
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on the L-tryptophan metabolism in children with Down's syndrome].
    Vassella F; Colombo JP; Gloor RD; Rossi E
    Helv Paediatr Acta; 1968 Aug; 23(4):419-28. PubMed ID: 4234242
    [No Abstract]   [Full Text] [Related]  

  • 9. [Down's syndrome and chromosomal mosaicism].
    Morić-Petrović S; Kalicanin P; Garzicić B; Zivković S
    Srp Arh Celok Lek; 1970 Jan; 98(1):65-74. PubMed ID: 4250163
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chromosome findings in 300 patients with Down's syndrome].
    Zizka J; Balicek P
    Kinderarztl Prax; 1980 Mar; 48(3):134-8. PubMed ID: 6446615
    [No Abstract]   [Full Text] [Related]  

  • 11. Intellectual, behavioral, and physical characteristics associated with trisomy, translocation, and mosaic types of Down's syndrome.
    Johnson RC; Abelson RB
    Am J Ment Defic; 1969 May; 73(6):852-5. PubMed ID: 4239502
    [No Abstract]   [Full Text] [Related]  

  • 12. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical symptoms of Down's syndrome and its variations].
    Seidlitz G
    Padiatr Grenzgeb; 1974; 13(4):205-17. PubMed ID: 4281904
    [No Abstract]   [Full Text] [Related]  

  • 14. [Significance of the type of chromosome aberrations and biochemical disorders for diagnosis of Down's syndrome and the phenotype of partial trisomy 21].
    Mikiel-Kostyra K; Czerski P; Bartosz G; Sito A; Leyka W
    Pediatr Pol; 1980 Jan; 55(1):23-32. PubMed ID: 6445053
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cytogenetic studies in children with Down's syndrome and in their relatives].
    Ostojska J
    Pediatr Pol; 1972 Oct; 47(10):1231-8. PubMed ID: 4263834
    [No Abstract]   [Full Text] [Related]  

  • 16. Dermatoglyphics and level of retardation in Down's syndrome.
    Dicker L
    Am J Ment Defic; 1972 Sep; 77(2):143-8. PubMed ID: 4263565
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative analysis of the rates of chromosome damage induced by bleomycin radiomimetic in human trisomic and diploid lymphocytes: in vitro cultures from a mosaic of a Down's syndrome individual.
    Cano J; Caparros MM; Pretel A
    Cytobios; 1995; 83(334):159-66. PubMed ID: 8620688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-rich plasma 5-hydroxytryptamine, urinary 5-hydroxyindoleacetic acid and tryptophan ingestion in mongols.
    Airaksinen EM
    J Ment Defic Res; 1971 Dec; 15 Pt 4(0):244-56. PubMed ID: 4279295
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of dermal patterns in Down's syndrome by predictive discrimination. I. Preliminary analysis based on frequencies of patterns.
    Borgaonkar DS; Davis M; Bolling DR; Herr HM
    Johns Hopkins Med J; 1971 Mar; 128(3):141-52. PubMed ID: 4251839
    [No Abstract]   [Full Text] [Related]  

  • 20. 5-hydroxyindoleacetic acid in children with Down's syndrome.
    Andersson H; Fällström SP; Lundborg P; Roos BE
    Acta Paediatr Scand; 1973 Mar; 62(2):158-60. PubMed ID: 4266256
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.